Info

Hopkins PM, Aboyoun CL, Chajed PN et al. Prospective analysis of 1235 transbronchial lung biopsies in lung transplant recipients. J Heart Lung Transplant 2002; 21:1062-1067.

Yousem SA, Berry GJ, Cagle PT et al. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung rejection study group. J Heart Lung Transplant 1996; 15(1Pt 1):1-5.

Sharples LD, McNeil K, Stewart S et al. Risk factors for bronchiolitis obliterans: a systematic review of recent publications. J Heart Lung transplant 2002; 21:271-281. Husain AN, Siddique MT, Holmes EW et al. Analysis of risk factors for the development of bronchiolitis obliterans syndrome. Am J Resp Crit Care Med 1999; 159:829-833.

Estenne M, Maurer JR, Boehler A et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 2002; 21:297-310. Snell GI, Esmore DS, Williams TJ. Cytolytic therapy for the bronchiolitis obliterans syndrome complicating lung transplantation. Chest 1996; 109:874-878. Kesten S, Chaparro C, Scavuzzo M et al. Tacrolimus as rescue therapy for bronchi-olitis obliterans syndrome. J Heart lung Transplant 1997; 16:905-912. Cairn J, Yek T, Banner NR et al. Time-related changes in pulmonary function after conversion to tacrolimus in bronchiolitis obliterans syndrome. J Heart Lung Transplant 2003; 22:50-57.

Fieguth HG, Krueger S, Wiedenmann DE et al. Tacrolimus for treatment of bron-chiolitis obliterans syndrome after unilateral and bilateral lung transplantation: Transplant Proc 2002; 34:1884.

Chaparro C, Maurer J, de Hoyos A et al. Causes of death in lung transplant patients J Heart Lung Transplant 1994; 13:758-766.

Chaparro C, Chamberlain D, de Hoyos A et al. Acute lung injury in lung allografts. J Heart Lung Transplant 1995; 14:267-273.

0 0

Post a comment